As expected, visual evaluation of DAT-SPECT scans showed asymmetric dopaminergic uptake in PD patients, resulting in positive findings for all cases, while none of the ET patients demonstrated qualitative reduction of DAT binding. Here, SLC6A3 is linked to Parkinson disease.